OverviewSuggest Edit

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases.

TypePublic
Founded1979
HQPlymouth Meeting, PA, US
Websiteinovio.com
Employee Ratings3.5
Overall CultureA+

Latest Updates

Employees (est.) (Feb 2019)281(+2%)
Revenue (FY, 2019)$4.1 M(-86%)
Share Price (Jan 2021)$10.1 (+5%)
Cybersecurity ratingCMore

Key People/Management at Inovio Pharmaceuticals

Angel Cabrera

Angel Cabrera

Director
Peter Kies

Peter Kies

Chief Financial Officer
Jacqueline Shea

Jacqueline Shea

Chief Operating Officer
Laurent Humeau

Laurent Humeau

Chief Scientific Officer
Prakash Bhuyan

Prakash Bhuyan

Vice President, Clinical Development
Jean D. Boyer

Jean D. Boyer

Vice President, Analytical Sciences
Show more

Inovio Pharmaceuticals Office Locations

Inovio Pharmaceuticals has offices in Plymouth Meeting and San Diego
Plymouth Meeting, PA, US (HQ)
660 W Germantown Pike #110
San Diego, CA, US
10480 Wateridge Cir
San Diego, CA, US
6769 Mesa Ridge Rd
Show all (3)

Inovio Pharmaceuticals Financials and Metrics

Inovio Pharmaceuticals Revenue

Inovio Pharmaceuticals's revenue was reported to be $4.11 m in FY, 2019
USD

Revenue (Q2, 2020)

267.2k

Net income (Q2, 2020)

(129.2m)

EBIT (Q2, 2020)

(33.2m)

Market capitalization (19-Jan-2021)

1.7b

Closing stock price (19-Jan-2021)

10.1

Cash (30-Jun-2020)

215.4m

EV

1.5b
Inovio Pharmaceuticals's current market capitalization is $1.7 b.
Annual
USDFY, 2011FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

9.8m13.5m10.5m40.6m35.4m42.2m30.5m4.1m

Revenue growth, %

(22%)288%(79%)

General and administrative expense

12.0m13.6m15.9m18.1m23.9m28.3m29.3m27.2m

R&D expense

20.0m21.4m34.1m57.8m88.7m98.6m95.3m88.0m
Quarterly
Annual
USDFY, 2011FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

17.4m33.7m40.5m57.6m19.1m23.8m23.7m22.2m

Accounts Receivable

467.9k3.3m2.8m7.3m15.8m6.0m3.3m700.1k

Prepaid Expenses

746.0k637.4k798.0k917.3k2.6m1.4m1.6m

Inventories

1.7m
USDQ2, 2011

Financial Leverage

1.2 x
Show all financial metrics

Inovio Pharmaceuticals Operating Metrics

FY, 2016

Patents Issued

620
Show all operating metrics

Inovio Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

Inovio Pharmaceuticals Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Inovio Pharmaceuticals Online and Social Media Presence

Embed Graph

Inovio Pharmaceuticals Company Culture

  • Overall Culture

    A+

    95/100

  • CEO Rating

    A+

    100/100

  • Compensation

    A+

    95/100

Learn more on Comparably

Inovio Pharmaceuticals News and Updates

Thinking about buying stock in Tcr2 Therapeutics, Inovio Pharmaceuticals, BioLineRx, Plug Power, or Arbutus Biopharma?

NEW YORK, Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TCRR, INO, BLRX, PLUG, and ABUS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Co-Diagnostics, Janus Henderson Group, Sorrento Therapeutics, Inovio Pharmaceuticals, or American Airlines?

NEW YORK, Oct. 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CODX, JHG, SRNE, INO, and AAL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Workhorse Group, Altimmune, Endo International, Inovio Pharmaceuticals, or Kaleido Biosciences?

NEW YORK, Sept. 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WKHS, ALT, ENDP, INO, and KLDO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about trading options or stock in GameStop, Fulgent Genetics, Inovio Pharmaceuticals, Quidel Corp, or United Airlines?

NEW YORK, Sept. 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GME, FLGT, INO, QDEL, and UAL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

Inovio Pharmaceuticals Stock Could See More Downside From $16

After a massive 2.5x rise since the March 23 lows of this year, at the current price of around $16 per share we believe Inovio Pharmaceuticals stock has run its course, and any significant upside from these levels is unlikely. INO stock has been very volatile in trade this week, and despite...

Thinking about buying stock in Can Fite Biopharma, Inovio Pharmaceuticals, Penn National Gaming, Delta Air Lines, or Advanced Micro Devices?

NEW YORK, Sept. 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CANF, INO, PENN, DAL, and AMD. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

Inovio Pharmaceuticals Frequently Asked Questions

  • When was Inovio Pharmaceuticals founded?

    Inovio Pharmaceuticals was founded in 1979.

  • Who are Inovio Pharmaceuticals key executives?

    Inovio Pharmaceuticals's key executives are Angel Cabrera, Peter Kies and Jacqueline Shea.

  • How many employees does Inovio Pharmaceuticals have?

    Inovio Pharmaceuticals has 281 employees.

  • What is Inovio Pharmaceuticals revenue?

    Latest Inovio Pharmaceuticals annual revenue is $4.1 m.

  • What is Inovio Pharmaceuticals revenue per employee?

    Latest Inovio Pharmaceuticals revenue per employee is $14.6 k.

  • Who are Inovio Pharmaceuticals competitors?

    Competitors of Inovio Pharmaceuticals include Evotec, Cocrystal Pharma and Cidara Therapeutics.

  • Where is Inovio Pharmaceuticals headquarters?

    Inovio Pharmaceuticals headquarters is located at 660 W Germantown Pike #110, Plymouth Meeting.

  • Where are Inovio Pharmaceuticals offices?

    Inovio Pharmaceuticals has offices in Plymouth Meeting and San Diego.

  • How many offices does Inovio Pharmaceuticals have?

    Inovio Pharmaceuticals has 3 offices.